Molecular biology for stage II colorectal cancer: The jury is still out [5]

Journal of Clinical Oncology

Volumn 25, Issue 19, 2007, Pages 2861-

  Cascinu, Stefano ^a   Zaniboni, Alberto ^b   Scartozzi, Mario ^a   Meriggi, Fausto ^b  

^a OSPEDALI RIUNITI   (Italy)

^b Oncologia Medica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER STAGING; COLORECTAL CANCER; GENE EXPRESSION; HUMAN; LETTER; LYMPHADENECTOMY; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; COLORECTAL TUMOR; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; NOTE; PROGNOSIS; RISK;

TUMOR MARKER;

COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 34447535451     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.10.0966     Document Type: Letter

References (3)

1. Barrier A, Boelle PY, Roser F, et al: Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol 24:4685-4691, 2006
2. Wang Y, Jatkoe T, Zhang Y, et al: Gene expression profiling and molecular markers to predict recurrence of Dukes'B colon cancer. J Clin Oncol 22:1564-1571, 2004
3. Benson AB III, Schrag D, Somerfield MR, et al: American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22:3408-3419, 2004